278.43
price up icon2.66%   7.2999
 
loading
Schlusskurs vom Vortag:
$271.13
Offen:
$266.93
24-Stunden-Volumen:
138.59K
Relative Volume:
0.31
Marktkapitalisierung:
$10.44B
Einnahmen:
$1.16B
Nettoeinkommen (Verlust:
$34.55M
KGV:
323.76
EPS:
0.86
Netto-Cashflow:
$134.18M
1W Leistung:
+1.16%
1M Leistung:
-2.49%
6M Leistung:
+44.20%
1J Leistung:
+31.60%
1-Tages-Spanne:
Value
$265.76
$279.30
1-Wochen-Bereich:
Value
$258.95
$279.30
52-Wochen-Spanne:
Value
$148.00
$310.00

Penumbra Inc Stock (PEN) Company Profile

Name
Firmenname
Penumbra Inc
Name
Telefon
(510) 995-2486
Name
Adresse
ONE PENUMBRA PLACE, ALAMEDA, CA
Name
Mitarbeiter
4,500
Name
Twitter
@penumbrainc
Name
Nächster Verdiensttermin
2025-02-18
Name
Neueste SEC-Einreichungen
Name
PEN's Discussions on Twitter

Vergleichen Sie PEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
PEN
Penumbra Inc
278.52 10.44B 1.16B 34.55M 134.18M 0.86
Medical Devices icon
ABT
Abbott Laboratories
131.65 225.32B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
100.86 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
375.54 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.65 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
72.20 42.10B 5.72B 4.17B 259.90M 6.97

Penumbra Inc Stock (PEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-14 Eingeleitet BofA Securities Buy
2025-01-21 Eingeleitet UBS Buy
2024-12-17 Eingeleitet Oppenheimer Outperform
2024-12-11 Hochstufung Wells Fargo Equal Weight → Overweight
2024-09-18 Eingeleitet Stifel Buy
2024-09-03 Eingeleitet Leerink Partners Outperform
2024-07-31 Herabstufung Citigroup Buy → Neutral
2024-07-31 Herabstufung Wells Fargo Overweight → Equal Weight
2024-02-23 Herabstufung JP Morgan Overweight → Neutral
2023-09-06 Eingeleitet Morgan Stanley Equal-Weight
2023-07-19 Eingeleitet Robert W. Baird Outperform
2023-03-29 Herabstufung Needham Buy → Hold
2023-01-30 Eingeleitet Piper Sandler Overweight
2022-11-04 Hochstufung Citigroup Neutral → Buy
2022-10-12 Eingeleitet Jefferies Buy
2022-10-05 Herabstufung Citigroup Buy → Neutral
2022-09-09 Hochstufung Needham Hold → Buy
2022-07-18 Eingeleitet RBC Capital Mkts Outperform
2022-04-19 Eingeleitet Deutsche Bank Buy
2022-03-08 Eingeleitet Needham Hold
2021-09-16 Eingeleitet Truist Buy
2021-06-04 Hochstufung BTIG Research Neutral → Buy
2020-12-16 Herabstufung BTIG Research Buy → Neutral
2020-10-07 Fortgesetzt Canaccord Genuity Buy
2020-09-29 Eingeleitet BTIG Research Buy
2020-09-08 Herabstufung BofA Securities Buy → Neutral
2020-03-05 Eingeleitet Citigroup Buy
2019-06-13 Bestätigt BofA/Merrill Buy
2019-05-30 Hochstufung JP Morgan Neutral → Overweight
2019-05-21 Eingeleitet William Blair Outperform
2018-10-29 Fortgesetzt BofA/Merrill Buy
2018-10-08 Eingeleitet RBC Capital Mkts Outperform
2018-02-21 Eingeleitet William Blair Outperform
2018-01-02 Herabstufung JP Morgan Overweight → Neutral
2015-11-30 Bestätigt Canaccord Genuity Buy
2015-10-13 Eingeleitet Wells Fargo Outperform
Alle ansehen

Penumbra Inc Aktie (PEN) Neueste Nachrichten

pulisher
09:00 AM

Breakthrough Clinical Data: Penumbra's CAVT Slashes Hospital Stays by 46%, Achieves 99% Success Rate - Stock Titan

09:00 AM
pulisher
Apr 01, 2025

Meiji Yasuda Asset Management Co Ltd. Buys New Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat

Apr 01, 2025
pulisher
Mar 29, 2025

ROSEN, A LEADING LAW FIRM, Encourages Penumbra, Inc. Investors to Secure Counsel Before Important March 16 DeadlinePEN - PR Newswire

Mar 29, 2025
pulisher
Mar 28, 2025

Penumbra Insider Sold Shares Worth $3,405,253, According to a Recent SEC Filing - MarketScreener

Mar 28, 2025
pulisher
Mar 27, 2025

Penumbra director Arani sells $3.41 million in stock - Investing.com India

Mar 27, 2025
pulisher
Mar 26, 2025

Thrombectomy Devices Market Surge: Key Players & Future Outlook - openPR.com

Mar 26, 2025
pulisher
Mar 25, 2025

New Thrombectomy Product Launches Support PEN Stock Amid Macro Issues - MSN

Mar 25, 2025
pulisher
Mar 22, 2025

Penumbra CEO Adam Elsesser sells $4.59 million in stock By Investing.com - Investing.com Australia

Mar 22, 2025
pulisher
Mar 21, 2025

Penumbra CEO Adam Elsesser sells $4.59 million in stock - Investing.com

Mar 21, 2025
pulisher
Mar 21, 2025

Do Its Financials Have Any Role To Play In Driving Penumbra, Inc.'s (NYSE:PEN) Stock Up Recently? - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Has Penumbra, Inc.'s (NYSE:PEN) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - simplywall.st

Mar 21, 2025
pulisher
Mar 20, 2025

Penumbra (PEN) Down 8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 20, 2025
pulisher
Mar 20, 2025

Peering Into Penumbra's Recent Short Interest - Benzinga

Mar 20, 2025
pulisher
Mar 17, 2025

B of A Securities Initiates Coverage of Penumbra (BMV:PEN) with Buy Recommendation - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Penumbra, Inc. Investors of Important Deadline in Securities Class Action – PEN - Business Wire

Mar 17, 2025
pulisher
Mar 16, 2025

Penumbra Inc (PEN) Trading 4.6% Higher on Mar 17 - GuruFocus.com

Mar 16, 2025
pulisher
Mar 15, 2025

Penumbra Inc (PEN) Shares Up 4.6% on Mar 15 - GuruFocus.com

Mar 15, 2025
pulisher
Mar 14, 2025

Penumbra launched at BofA with Buy on a broad rollout of Flash 2.0 - MSN

Mar 14, 2025
pulisher
Mar 14, 2025

What Analysts Are Saying About Penumbra Stock - Benzinga

Mar 14, 2025
pulisher
Mar 14, 2025

Penumbra stock launched at BofA with Buy (PEN:NYSE) - Seeking Alpha

Mar 14, 2025
pulisher
Mar 14, 2025

B of A Securities Initiates Coverage of Penumbra (PEN) with Buy Recommendation - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

Penumbra initiated with a Buy at BofA - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Penumbra, Inc. (NYSE:PEN) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Penumbra, Inc. (NYSE:PEN) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Penumbra Off And Running On Renewed Enthusiasm For Mechanical Thrombectomy - Seeking Alpha

Mar 12, 2025
pulisher
Mar 09, 2025

Adam Elsesser Sells 61,600 Shares of Penumbra, Inc. (NYSE:PEN) Stock - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Johanna Roberts Sells 600 Shares of Penumbra, Inc. (NYSE:PEN) Stock - MarketBeat

Mar 09, 2025
pulisher
Mar 07, 2025

Penumbra CEO Adam Elsesser sells $17.47 million in stock By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

Penumbra CEO Adam Elsesser sells $17.47 million in stock - Investing.com

Mar 07, 2025
pulisher
Mar 06, 2025

Penumbra director O’Rourke sells $14,274 in stock By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Penumbra director Arani sells $3.45 million in stock By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Penumbra’s Growth Potential Balanced by Market Uncertainties: A Hold Recommendation - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Insider Sell: Bridget O'Rourke Sells Shares of Penumbra Inc (PEN) - GuruFocus

Mar 06, 2025
pulisher
Mar 06, 2025

Penumbra, Inc. to Host Earnings Call - ACCESS Newswire

Mar 06, 2025
pulisher
Mar 05, 2025

Insider Sell: Arani Bose Sells 12,000 Shares of Penumbra Inc (PE - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra director O’Rourke sells $14,274 in stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra EVP Johanna Roberts sells shares worth $172,458 - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra EVP Johanna Roberts sells shares worth $172,458 By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra’s chief accounting officer sells shares worth over $2.2 million - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra CFO Maggie Yuen sells $571,994 in stock - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra director Arani sells $3.45 million in stock - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Penumbra Announces Board Transition with Kassing’s Retirement - TipRanks

Mar 05, 2025
pulisher
Mar 04, 2025

Aspiration-first approaches gather further traction thanks to ‘game-changing’ thrombectomy technologies - NeuroNews International

Mar 04, 2025
pulisher
Mar 03, 2025

Penumbra Inc.: Will Its Market Penetration & Access Initiatives Help Capture The Thrombectomy Market? - Smartkarma

Mar 03, 2025

Finanzdaten der Penumbra Inc-Aktie (PEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices STE
$227.62
price up icon 0.80%
medical_devices ZBH
$112.47
price up icon 0.09%
medical_devices PHG
$24.92
price down icon 1.17%
$67.12
price down icon 0.77%
$79.03
price down icon 0.72%
medical_devices EW
$72.21
price up icon 0.49%
Kapitalisierung:     |  Volumen (24h):